AmpliPhi Biosciences Corporation (NYSEMKT:APHB) will be releasing its earnings data after the market closes on Monday, August 14th. Analysts expect AmpliPhi Biosciences Corporation to post earnings of ($0.80) per share for the quarter.

Shares of AmpliPhi Biosciences Corporation (NYSEMKT APHB) traded down 1.2169% during trading on Tuesday, hitting $0.8199. 14,824 shares of the stock traded hands. AmpliPhi Biosciences Corporation has a one year low of $0.67 and a one year high of $21.70. The firm has a 50 day moving average price of $1.96 and a 200-day moving average price of $1.02. The company’s market cap is $5.43 million.

COPYRIGHT VIOLATION WARNING: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at

About AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for AmpliPhi Biosciences Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmpliPhi Biosciences Corporation and related companies with's FREE daily email newsletter.